Open Access
Issue
BIO Web Conf.
Volume 200, 2025
Biology, Health & Artificial Intelligence Conference (BHAI 2025)
Article Number 01019
Number of page(s) 11
DOI https://doi.org/10.1051/bioconf/202520001019
Published online 05 December 2025
  • Bloom, P. P. & Young, V. B. Microbiome therapeutics for the treatment of recurrent Clostridioides difficile infection. Expert Opin. Biol. Ther. 23, 89–101 (2023). [Google Scholar]
  • Chen, P. et al. Structural basis for CSPG4 as a receptor for TcdB and a therapeutic target in Clostridioides difficile infection. Nat. Commun. 12, 3748 (2021). [Google Scholar]
  • Kordus, S. L., Thomas, A. K. & Lacy, D. B. Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics. Nat. Rev. Microbiol. 20, 285–298 (2022). [Google Scholar]
  • Ridlon, J. M. & Gaskins, H. R. Another renaissance for bile acid gastrointestinal microbiology. Nat. Rev. Gastroenterol. Hepatol. https://doi.org/10.1038/s41575-024-00896-2 (2024). [Google Scholar]
  • La Vecchia, A.; Ippolito, G.; Taccani, V.; Gatti, E.; Bono, P.; Bettocchi, S.; Pinzani, R.; Tagliabue, C.; Bosis, S.; Marchisio, P.; et al. Epidemiology and antimicrobial susceptibility of Staphylococcus aureus in children in a tertiary care pediatric hospital in Milan, Italy, 2017–2021. Ital. J. Pediatr. 2022, 48, 67. [Google Scholar]
  • Williams, A.; Coombs, G.W.; Bell, J.M.; Daley, D.A.; Mowlaboccus, S.; Bryant, P.; Campbell, A.; Cooley, L.; Iredell, J.; Irwin, A.D.; et al. Antimicrobial resistance in Staphylococcus aureus and Enterococci spp. isolates from bloodstream infections in Australian children, 2013–2021. J. Pediatr. Infect. Dis. Soc. 2024; piae110 [Google Scholar]
  • Hoyer, E.A.; Joseph, M.; Kaplan, S.L.; Vallejo, J.G.; McNeil, J.C. Predictive Factors to Guide Empiric Antimicrobial Therapy of Acute Hematogenous Osteomyelitis in Children. Pediatr. Infect. Dis. J. 2023, 42, 449–455 [Google Scholar]
  • McDaniel, L.M.; Fiawoo, S.; Tamma, P.D.; Same, R.G. Trimethoprim-Sulfamethoxazole for Pediatric Osteoarticular Infections. J. Pediatr. Infect. Dis. Soc. 2023, 12, 534–539 [Google Scholar]
  • Glaser, M.A.; Hughes, L.M.; Jnah, A.; Newberry, D. Neonatal Sepsis: A Review of Pathophysiology and Current Management Strategies. Adv. Neonatal Care 2021, 21, 49–60 [Google Scholar]
  • Wang, J.; Zhang, H.; Yan, J.; Zhang, T. Literature review on the distribution characteristics and antimicrobial resistance of bacterial pathogens in neonatal sepsis. J. Matern. Fetal Neonatal Med. 2022, 35, 861–870 [Google Scholar]
  • Tan, J.; Wang, Y.; Gong, X.; Li, J.; Zhong, W.; Shan, L.; Lei, X.; Zhang, Q.; Zhou, Q.; Zhao, Y.; et al. Antibiotic resistance in neonates in China 2012–2019: A multicenter study. J. Microbiol. Immunol. Infect. 2022, 55, 454–462 [Google Scholar]
  • Rallis, D.; Giapros, V.; Serbis, A.; Kosmeri, C.; Baltogianni, M. Fighting antimicrobial resistance in neonatal intensive care units: Rational use of antibiotics in neonatal sepsis. Antibiotics 2023, 12, 508. [Google Scholar]
  • Ibrahim, S.; Al-Saryi, N.; Al-Kadmy, I.M.; Aziz, S.N. Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals. Mol. Biol. Rep. 2021, 48, 6987–6998. [Google Scholar]
  • Ting, J.Y.; Autmizguine, J.; Dunn, M.S.; Choudhury, J.; Blackburn, J.; Gupta-Bhatnagar, S.; Assen, K.; Emberley, J.; Khan, S.; Leung, J.; et al. Practice summary of antimicrobial therapy for commonly encountered conditions in the neonatal intensive care unit: A Canadian perspective. Front. Pediatr. 2022, 10, 894005 [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.